Wednesday, December 6, 2023
Clinical Advances in
Hyperhidrosis, or excessive sweating, is a common condition that affects more people than previously reported. Approximately 15.3 million Americans suffer from this disease. The burden of hyperhidrosis on quality of life is substantial, affecting patients’ work, social, and leisure activities, as well as interpersonal relationships. Recent advances in the understanding of hyperhidrosis have led to an increased ability for earlier diagnosis of this disease, resulting in improved management and patient outcomes.
Supported by an independent educational grant from
Dermira, Inc.
Steering Committee Chair
Professor, Department of Dermatology
Eastern Virginia Medical School
Norfolk, Virginia
Professor and Interim Chair of Dermatology
Residency Program Director
Director of Translational Research
Director of Supportive Oncodermatology
George Washington University School of Medicine and Health Sciences
Washington, District of Columbia
Professor of Dermatology and Pediatrics
UT Health Science Center
Houston McGovern Medical School
Houston, Texas
Adjunct Clinical Professor
Department of Dermatology
Emory University School of Medicine
Associate Physician
Dermatology Associates of Georgia
Atlanta, Georgia
Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Children's Hospital
University of Washington School of Medicine
Seattle, Washington
Nurse Practitioner
Modern Dermatology
Dallas, Texas
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Atacama Therapeutics; Bickel Biotechnology; Biofrontera AG; Celgene Corporation; Dermira Inc.; DUSA Pharmaceuticals, Inc.; LEO Pharma Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Promius Pharma, LLC; Promlus Pharmaceuticals; Regeneron Pharmaceuticals, Inc.; Sanofi; TDM SurgiTech, Inc.; TheraVida; Valeant Pharmaceuticals International
Received grants for clinical research from: Abbott Laboratories; Amgen Inc.; Asana Biosciences, LLC; Bickel Biotechnology; Celgene Corporation; Dermavant Sciences, Inc.; Eli Lilly and Company; LEO Pharma Inc.; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk A/S; Ortho Dermatologics; Peplin Inc.; Pfizer Inc.; Photocure USA; Promius Pharma, LLC; Regeneron Pharmaceuticals, Inc.; Stiefel Laboratories; Valeant Pharmaceuticals International
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Aclaris; Allergan, Inc.; Aveeno; Berg; Biogen; Dermira Inc.; Encore; Exeltis; G&W Laboratories; Galderma Laboratories, L.P.; Intraderm; La Roche Posay; Lilly; L'Oreal; Menlo; Microcures; Novartis Pharmaceuticals Corporation; Occulus; Pfizer Inc.; Sanova Works; Valeant Pharmaceuticals International; Zylo Therapeutics
Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Dermira Inc.; Janssen Pharmaceuticals; Regeneron Pharmaceuticals, Inc.
Received grants for clinical research from: Aclaris; Kiniksa Pharmaceuticals
Owns stock, stock options, or bonds from: Intraderm; Microcures; Zylo Therapeutics
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Almirall Hermal GmbH ; Cutanea; Pfizer Inc.; Pierre Fabre; Dermira Inc.; Dermavant Sciences, Inc.; Valeant Pharmaceuticals International; Verrica
Served as a speaker or a member of a speakers bureau for: Almirall Hermal GmbH ; Amgen Inc.; Cutanea; Dermira Inc.; Pfizer Inc.; Valeant Pharmaceuticals International
Received grants for clinical research from: Allerfan; Amgen Inc.; Brickell; Cutanea; Medimetriks; Pfizer Inc.; Sienna; Valeant Pharmaceuticals International
Other: DSMB: GlaxoSmithKline; Regeneron Pharmaceuticals, Inc.; Sanofi
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Dermira Inc.; Pfizer Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Micreos
Received grants for clinical research from: Sanofi-Regeneron Pharmaceuticals, Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Received grants for clinical research from: Dermira Inc.